Simple blood test could help GPs catch Alzheimer's early

NCT ID NCT07466394

Recruiting now Diagnosis Sponsor: Robert Perneczky Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study aims to improve early detection of Alzheimer's disease in people aged 60 and older. Researchers will equip general practitioners and specialists with digital cognitive tests and blood-based biomarkers to identify those with early cognitive decline. The goal is to create a practical screening system that can be used in routine medical care, helping more people access future treatments sooner.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Blood-based biomarker testing
What this could lead to: If successful, this could create a practical system for GPs to identify early Alzheimer's, enabling timely access to future treatments.
What could go wrong: This is an observational study focused on diagnosis, not treatment. The blood tests may not be accurate enough in real-world settings, and results may not apply outside Germany.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER'S DISEASE(AD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALZHEIMER'S DISEASE(AD)

Contacts and locations

Locations

Klinik für Psychiatrie und Psychotherapie am LMU Klinikum
RECRUITING

München, 80336, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.